Tony Butler
Stock Analyst at Rodman & Renshaw
(0.74)
# 4,044
Out of 5,099 analysts
95
Total ratings
32.26%
Success rate
-13.51%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $16.83 | +48.54% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $1.03 | +967.96% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.54 | +1,068.83% | 4 | Sep 26, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $0.59 | +2,604.53% | 5 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.09 | +817.43% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $57.59 | +30.23% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $96.77 | -63.83% | 7 | Aug 8, 2023 | |
| GTBP GT Biopharma | Reiterates: Hold | $60 | $0.67 | +8,821.93% | 5 | Aug 7, 2023 | |
| CGEN Compugen | Reiterates: Buy | $13 | $1.63 | +697.55% | 6 | Aug 7, 2023 | |
| BCYC Bicycle Therapeutics | Reiterates: Buy | $50 | $7.52 | +564.89% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.48 | +913.51% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.77 | +3,131.23% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $4.29 | +249.65% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $6.53 | +53.14% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $4.56 | +272.81% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $4.09 | +3,958.68% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $9.82 | +511.00% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $1.77 | +13,459.32% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.28 | +2,042.86% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $2.00 | +17,900.00% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $6.12 | -67.32% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.75 | +757.14% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $1.45 | +589.66% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $5.25 | +185.71% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $9.37 | +1,073.96% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $960 | $11.69 | +8,112.15% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $16.83
Upside: +48.54%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $1.03
Upside: +967.96%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.54
Upside: +1,068.83%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.59
Upside: +2,604.53%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.09
Upside: +817.43%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $57.59
Upside: +30.23%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $96.77
Upside: -63.83%
GT Biopharma
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $0.67
Upside: +8,821.93%
Compugen
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.63
Upside: +697.55%
Bicycle Therapeutics
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $7.52
Upside: +564.89%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.48
Upside: +913.51%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.77
Upside: +3,131.23%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $4.29
Upside: +249.65%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $6.53
Upside: +53.14%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $4.56
Upside: +272.81%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $4.09
Upside: +3,958.68%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $9.82
Upside: +511.00%
Jun 5, 2023
Reiterates: Buy
Price Target: $240
Current: $1.77
Upside: +13,459.32%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.28
Upside: +2,042.86%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $2.00
Upside: +17,900.00%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $6.12
Upside: -67.32%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $1.75
Upside: +757.14%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $1.45
Upside: +589.66%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $5.25
Upside: +185.71%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $9.37
Upside: +1,073.96%
Mar 2, 2020
Initiates: Buy
Price Target: $960
Current: $11.69
Upside: +8,112.15%